Skip to main content

Table 1 Clinical patient characteristics

From: Clinical relevance of circulating angiogenic cells in patients with ischemic stroke

Characteristic

 

Median, range, sample size

 

Age

72, 31–103, 187

Basal NIHSS

7.28, 0–25, 139

NIHSS (7 day)

3.17, 0–24, 115

Percentage, sample size

 

Sex (woman)

33.6%, 49

IV rtPA

24.7%, 36

Hypertension

82.6%, 123

Diabetes mellitus

42.3%, 63

Hyperlipidemia

66.9%, 99

Current Smoking

25.9%, 38

Alcohol

12.9%, 19

Stroke etiology (TOAST)

 

 Atheromatous

12.9%, 24

 Cardioembolic

35.2%, 65

 Lacunar

9.7%, 18

 Infrequent etiology

3.2%, 6

 Undetermined etiology

39%, 72

  1. Basic demographic and clinical patient characteristics (NIHSS National Institute of Health Stroke Scale, IV rtPA intravenous recombinant tissue plasminogen activator, TOAST Trial of Org 10172 in Acute Stroke Treatment